ACADIA PHARMACEUTICALS INC (ACAD) Stock Profile — Insider Trades & Financials

Smart-Money SignalNeutral · 52/100— Insiders are net sellers over 90 days (-$171K, 2 sales vs 0 buys)

Revenue$308.0M

Net Income$31.5M

EPS$0.20

Market Cap$3.3B

Price Performance

Historical data including institutional events

Company Profile

Catherine Owen Adams

CEO & Executive Director

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Employees: 570
Headquarters: SAN DIEGO, CA, United States
Website: www.acadia-pharm.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Smart-Money SignalNeutral · 52/100— Insiders are net sellers over 90 days (-$171K, 2 sales vs 0 buys)

Revenue$308.0M

Net Income$31.5M

EPS$0.20

Market Cap$3.3B

Price Performance

Historical data including institutional events

Company Profile

Catherine Owen Adams

CEO & Executive Director

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Employees: 570
Headquarters: SAN DIEGO, CA, United States
Website: www.acadia-pharm.com

Peer ComparisonRevenue ($B)

▾

Smart-Money Signal

90-DAY POSTURE

52/ 100

NEUTRAL

Insiders are net sellers over 90 days (-$171K, 2 sales vs 0 buys). Smart-money posture is balanced.

Insider flow · 90d-$171K

Congress flow · 90dno activity

10b5-1 share99% planned

Cluster selling2 officers

Price vs 52w63% of high

Cross-Section Event Timeline

INSIDERS · CONGRESS · EARNINGS

INSIDER GRANT / AWARDEdmund Harrigan (Director) GRANT / AWARD ACADMay 29, 2026

INSIDER EXERCISE / CONVERSIONEdmund Harrigan (Director) EXERCISE / CONVERSION ACADMay 29, 2026

INSIDER GRANT / AWARDEdmund Harrigan (Director) GRANT / AWARD ACADMay 29, 2026

INSIDER SELLJames Kihara (PRINCIPAL ACCOUNTING OFFICER) SELL ACADJun 26, 2026

INSIDER EXERCISE / CONVERSIONElizabeth H.Z. Thompson (EVP, Head of Research & Dev) EXERCISE / CONVERSION ACADJul 29, 2026

INSIDER SELLElizabeth H.Z. Thompson (EVP, Head of Research & Dev) SELL ACADJul 30, 2026

INSIDER EXERCISE / CONVERSIONMark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) EXERCISE / CONVERSION ACADAug 5, 2026

INSIDER SELLMark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) SELL ACADAug 5, 2026

INSIDER SELLMark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) SELL ACADAug 6, 2026

INSIDER EXERCISE / CONVERSIONMark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) EXERCISE / CONVERSION ACADAug 6, 2026

⚡

Core Efficiency

ROE?

2.41%

ROA?

1.81%

D/E Ratio?

0.33

Op. Margin?

12.29%

📊

Profitability Ratios

Net Margin?

10.23%

Current Ratio?

3.39

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Oct 19, 2026 (in 7 days)

Quarterly Report (10-Q) — Based on filing pattern

Oct 19, 2026

Predicted10-Q

Aug 5, 2026

10-QQ2 202636d after period end

May 7, 2026

10-QQ1 202637d after period end

Feb 26, 2026

10-KQ4 20258d after period end

Nov 6, 2025

10-QQ3 20258d after period end

Aug 7, 2025

10-QQ2 20258d after period end

Data Freshness

Financial Data

2mo ago

Latest filing: 2026-08-05

SEC Metadata

2mo ago

Latest filing: 2026-08-05

Loading company sections...

ACADIA PHARMACEUTICALS INC

Price Performance

Company Profile

ACADIA PHARMACEUTICALS INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

ACADIA PHARMACEUTICALS INC

Price Performance

Company Profile

The morning brief, before the bell.

ACADIA PHARMACEUTICALS INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades